Brief: Imara Inc - Following The Asset Sale, Co Expects To Continue To Evaluate Its Strategic Alternatives
07/09/2022 11:59
Sept 7 (Reuters) - Imara Inc IMRA.O :
* IMARA INC - FOLLOWING THE ASSET SALE, CO EXPECTS TO
CONTINUE TO
EVALUATE ITS STRATEGIC ALTERNATIVES
Source text for Eikon: ID:nFWN30D1JJ
Further company coverage: IMRA.O
(Reporting by Pratik Jain)
((Pratik.Jain@thomsonreuters.com;))
Recent news on Enliven Therapeutics
See all newsBrief: Enliven Therapeutics Appoints Kristine Ball To Board Of Directors Ahead Of Planned Phase 3 Trial Initiation This Year
US RESEARCH ROUNDUP-Amrize, Dexcom, Lennar
U.S. RESEARCH ROUNDUP- Berkshire Hathaway, Exxon Mobil, Honeywell Technologies
U.S. RESEARCH ROUNDUP-Caterpillar, Eli Lilly, McKesson
Enliven Therapeutics Q2 net loss widens on higher expenses